How to understand the efficacy measurements for enterovirus type 71 vaccine?

References

• McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26:91 - 107; http://dx.doi.org/10.1111/j.1574-6976.2002.tb00601.x; PMID: 12007645
   PubMed Web of Science ®Google Scholar
• WHO. A Guide to clinical management and public health response for hand, foot and mouth disease (HFMD). 2011 [cited 2012 September 28]; Available from: http://www.wpro.who.int/publications/docs/GuidancefortheclinicalmanagementofHFMD.pdf
   Google Scholar
• Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, Nishio O. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 2002; 46:621 - 7; http://dx.doi.org/10.1111/j.1348-0421.2002.tb02743.x; PMID: 12437029
   PubMed Web of Science ®Google Scholar
• Huang FL, Chen CH, Huang SK, Chen PY. An outbreak of enterovirus 71 in a nursery. Scand J Infect Dis 2010; 42:609 - 12; http://dx.doi.org/10.3109/00365541003754444; PMID: 20429712
   PubMed Web of Science ®Google Scholar
• Liu C-C, Tseng H-W, Wang S-M, Wang J-R, Su I-J. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol 2000; 17:23 - 30; http://dx.doi.org/10.1016/S1386-6532(00)00068-8; PMID: 10814935
   PubMed Web of Science ®Google Scholar
• Ho M. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000; 33:205 - 16; PMID: 11269363
   PubMedGoogle Scholar
• Weng KF, Chen LL, Huang PN, Shih SR. Neural pathogenesis of enterovirus 71 infection. Microbes Infect 2010; 12:505 - 10; http://dx.doi.org/10.1016/j.micinf.2010.03.006; PMID: 20348010
   PubMed Web of Science ®Google Scholar
• Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother 2012; 8:668 - 74; http://dx.doi.org/10.4161/hv.19521; PMID: 22634437
   PubMed Web of Science ®Google Scholar
• Zhu FC, Liang ZL, Li XL, Ge HM, Meng FY, Mao QY, Zhang YT, Hu YM, Zhang ZY, Li JX, et al. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 2013; 381:1037 - 45; http://dx.doi.org/10.1016/S0140-6736(12)61764-4; PMID: 23352749
   PubMed Web of Science ®Google Scholar
• Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 2012; 30:3295 - 303; http://dx.doi.org/10.1016/j.vaccine.2012.03.010; PMID: 22426327
   PubMed Web of Science ®Google Scholar
• Chou AH, Liu CC, Chang CP, Guo MS, Hsieh SY, Yang WH, Chao HJ, Wu CL, Huang JL, Lee MS, et al. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS One 2012; 7:e34834; http://dx.doi.org/10.1371/journal.pone.0034834; PMID: 22529942
   PubMed Web of Science ®Google Scholar
• Huang ML, Ho MS, Lee MS. Enterovirus 71 vaccine: when will it be available?. J Formos Med Assoc 2011; 110:425 - 7; http://dx.doi.org/10.1016/S0929-6646(11)60063-6; PMID: 21742245
   PubMed Web of Science ®Google Scholar
• Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, Gao F, Wu X, Xu M, Wang J. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 2013; 9:1701 - 5; http://dx.doi.org/10.4161/hv.24949; PMID: 23744508
   PubMed Web of Science ®Google Scholar
• Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381:2024 - 32; http://dx.doi.org/10.1016/S0140-6736(13)61049-1; PMID: 23726161
   PubMed Web of Science ®Google Scholar
• Lachenbruch PA. Sensitivity, specificity, and vaccine efficacy. Control Clin Trials 1998; 19:569 - 74; http://dx.doi.org/10.1016/S0197-2456(98)00042-7; PMID: 9875836
   PubMedGoogle Scholar
• Chow SCL, J.P. Efficacy Trials Design and Analysis of Clinical Trials: Concepts and Methodologies. Second Edition ed: John Wiley & Sons, Inc.; 2004.
   Google Scholar
• Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol 2008; 49:103 - 12; http://dx.doi.org/10.1016/S1875-9572(08)60023-6; PMID: 19054914
   PubMedGoogle Scholar
• Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis 2012; 6:e1737; http://dx.doi.org/10.1371/journal.pntd.0001737; PMID: 22953003
   PubMed Web of Science ®Google Scholar
• Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, Hsu KH, Fang TY, Huang YC, Lin TY. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 2004; 291:222 - 7; http://dx.doi.org/10.1001/jama.291.2.222; PMID: 14722149
   PubMed Web of Science ®Google Scholar
• Simondon F, Khodja H. Capture-recapture method for estimating misclassification errors: application to the measurement of vaccine efficacy in randomized controlled trials. Int J Epidemiol 1999; 28:113 - 6; http://dx.doi.org/10.1093/ije/28.1.113; PMID: 10195674
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10:212 - 41; PMID: 3066628
   PubMed Web of Science ®Google Scholar
• Merovitz L, Demers AM, Newby D, McDonald J. Enterovirus 71 infections at a Canadian center. Pediatr Infect Dis J 2000; 19:755 - 7; http://dx.doi.org/10.1097/00006454-200008000-00017; PMID: 10959747
   PubMed Web of Science ®Google Scholar
• Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, Song XF, Yao X, Li JX, Ji H, et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 2012; 7:e37206; http://dx.doi.org/10.1371/journal.pone.0037206; PMID: 22662137
   PubMed Web of Science ®Google Scholar
• Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, Ning HC, Chung PW, Kang CM. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 1999; 18:1092 - 6; http://dx.doi.org/10.1097/00006454-199912000-00013; PMID: 10608631
   PubMed Web of Science ®Google Scholar
• Lim KA, Benyesh-Melnick M. Typing of viruses by combinations of antiserum pools. Application to typing of enteroviruses (Coxsackie and ECHO). J Immunol 1960; 84:309 - 17; PMID: 14416964
   PubMed Web of Science ®Google Scholar
• Chung PW, Huang YC, Chang LY, Lin TY, Ning HC. Duration of enterovirus shedding in stool. J Microbiol Immunol Infect 2001; 34:167 - 70; PMID: 11605806
   PubMedGoogle Scholar
• Singh S, Chow VT, Phoon MC, Chan KP, Poh CL. Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers. J Clin Microbiol 2002; 40:2823 - 7; http://dx.doi.org/10.1128/JCM.40.8.2823-2827.2002; PMID: 12149336
   PubMed Web of Science ®Google Scholar
• Brown BA, Kilpatrick DR, Oberste MS, Pallansch MA. Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol 2000; 16:107 - 12; http://dx.doi.org/10.1016/S1386-6532(00)00065-2; PMID: 10720814
   PubMed Web of Science ®Google Scholar
• Tan EL, Chow VT, Kumarasinghe G, Lin RT, Mackay IM, Sloots TP, Poh CL. Specific detection of enterovirus 71 directly from clinical specimens using real-time RT-PCR hybridization probe assay. Mol Cell Probes 2006; 20:135 - 40; http://dx.doi.org/10.1016/j.mcp.2005.11.003; PMID: 16460910
   PubMed Web of Science ®Google Scholar
• Tan EL, Yong LL, Quak SH, Yeo WC, Chow VT, Poh CL. Rapid detection of enterovirus 71 by real-time TaqMan RT-PCR. J Clin Virol 2008; 42:203 - 6; http://dx.doi.org/10.1016/j.jcv.2008.01.001; PMID: 18304867
   PubMed Web of Science ®Google Scholar
• Xu F, Yan Q, Wang H, Niu J, Li L, Zhu F, He S, Zhang S, Weng Z, Cheng T, et al. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One 2010; 5:e11388; http://dx.doi.org/10.1371/journal.pone.0011388; PMID: 20613983
   PubMedGoogle Scholar
• Han J, Ma XJ, Wan JF, Liu YH, Han YL, Chen C, Tian C, Gao C, Wang M, Dong XP. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery. BMC Infect Dis 2010; 10:178; http://dx.doi.org/10.1186/1471-2334-10-178; PMID: 20565813
   PubMed Web of Science ®Google Scholar
• Li J, Lin C, Qu M, Li X, Gao Z, Zhang X, Liu Y, Huang Y, Wang X, Jia L, et al. Excretion of enterovirus 71 in persons infected with hand, foot and mouth disease. Virol J 2013; 10:31; http://dx.doi.org/10.1186/1743-422X-10-31; PMID: 23343115
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10:778 - 90; http://dx.doi.org/10.1016/S1473-3099(10)70194-8; PMID: 20961813
   PubMed Web of Science ®Google Scholar
• Tan X, Huang X, Zhu S, Chen H, Yu Q, Wang H, Huo X, Zhou J, Wu Y, Yan D, et al. The persistent circulation of enterovirus 71 in People’s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 2011; 6:e25662; http://dx.doi.org/10.1371/journal.pone.0025662; PMID: 21980521
   PubMed Web of Science ®Google Scholar
• Lin TY, Chang LY, Hsia SH, Huang YC, Chiu CH, Hsueh C, Shih SR, Liu CC, Wu MH. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002; 34:Suppl 2 S52 - 7; http://dx.doi.org/10.1086/338819; PMID: 11938497
   PubMedGoogle Scholar
• Chang L-Y, Lin T-Y, Hsu K-H, Huang Y-C, Lin K-L, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354:1682 - 6; http://dx.doi.org/10.1016/S0140-6736(99)04434-7; PMID: 10568570
   PubMed Web of Science ®Google Scholar
• Paul Y. Herd immunity and herd protection. Vaccine 2004; 22:301 - 2; http://dx.doi.org/10.1016/j.vaccine.2003.07.016; PMID: 14670308
   PubMed Web of Science ®Google Scholar
• Kennett ML, Birch CJ, Lewis FA, Yung AP, Locarnini SA, Gust ID. Enterovirus type 71 infection in Melbourne. Bull World Health Organ 1974; 51:609 - 15; PMID: 4377551
   PubMed Web of Science ®Google Scholar
• Crawford NW, Graham SM. EV71 vaccine: protection from a previously neglected disease. Lancet 2013; 381:1968 - 70; http://dx.doi.org/10.1016/S0140-6736(13)61124-1; PMID: 23726163
   PubMed Web of Science ®Google Scholar